Chantal Nifle

Le Chesnay, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2026

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.

Journal: JAMA neurology
Published: August 04, 2025

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Journal: Neurology
Published: July 16, 2025

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.

High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.

Journal: JAMA
Published: March 10, 2025

Multiple Susceptibility-Weighted Imaging Hypointensities in Intravascular Large B-Cell Lymphoma.

Multiple Susceptibility-Weighted Imaging Hypointensities in Intravascular Large B-Cell Lymphoma.

Journal: Stroke
Published: November 05, 2024

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.

Journal: Neurology
Published: July 11, 2024

Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

Journal: JAMA neurology
Published: July 01, 2024

Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.

Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.

Journal: European journal of neurology
Published: May 07, 2024

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.

Journal: JAMA neurology
Published: March 25, 2024

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 14, 2022

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.

Journal: Neurology
Published: April 28, 2022

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

Journal: BMC medical research methodology
Published: January 14, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026